Ophelia blog · May 2025
Ophelia and Brave Health announced a partnership to connect opioid use disorder treatment with mental health services, including coordinated referrals and broader support for Medicaid-focused populations.
Medication & support to beat opioid addiction from home
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Ophelia is a New York-based healthcare company providing private, evidence-based opioid use disorder treatment at home via telehealth, local pharmacy pickup, and ongoing patient support.
Primary product
Telehealth-based medication-assisted treatment and care coordination for opioid use disorder (OUD)
Founded
2020
Headquarters
New York, New York, United States
Team size
100-150
Work style
Flexible
Industry
Mental Health Care
Sub-industry
Telehealth / opioid use disorder treatment
Offices
Business model
Leadership
Founder & CEO
Chief Operating Officer
Chief Commercial Officer
Chief Financial Officer
Vice President Clinical Operations
Senior Director of Partnerships
Jenni Friedman
Chief Marketing Officer
Eric Doran
Head of People
Adam Bisaga
Medical Director
Investors
Public evidence emphasizes evidence-based, judgment-free care, high-touch patient support, and a clinically oriented operating model. Public culture signals are limited beyond hiring posts and leadership content.
Work style
Flexible
Compensation
Public compensation data is limited. Exa surfaced an employer rating with compensation at 3.7/5 on one review set, but no salary ranges or formal pay policy were found.
Pricing
Insurance-reimbursed clinical treatment; public materials indicate contracts with Medicaid, Medicare, and commercial insurers, with patient cost depending on coverage.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Estimated monthly visits
824.4K
Traffic estimate as of Jun 2026
Ophelia blog · May 2025
Ophelia and Brave Health announced a partnership to connect opioid use disorder treatment with mental health services, including coordinated referrals and broader support for Medicaid-focused populations.
Ophelia blog · Apr 2025
Ophelia announced a strategic partnership with Spring Health to pair OUD treatment with therapy and psychiatric support for employers and health plans.
PR Newswire · Oct 2024
Ophelia expanded Medicaid coverage in New Jersey, broadening access to MOUD treatment statewide through new payer relationships.
PR Newswire · Jun 2024
Ophelia added Marc Russo and Trip Hofer to its board to support payer growth, network expansion, and Medicaid/commercial partnerships.
PR Newswire · Mar 2023
Leadership expansion announcement.
13 jobs at Ophelia